Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

Long-Term Monitoring and Life with FCCM

At a Glance

Living with Familial Cerebral Cavernous Malformation (FCCM) involves regular MRI monitoring of the brain and spine to track lesions. Most patients can live full, active lives—including exercising and having a healthy pregnancy—by working closely with a specialized care team.

Living with Familial Cerebral Cavernous Malformation (FCCM) means entering a long-term partnership with your medical team. Because FCCM is a dynamic condition where new lesions can form or existing ones can change, consistent monitoring is the cornerstone of your health strategy [1][2]. While the idea of lifelong “watching” can be stressful, it is a proactive way to stay ahead of the condition and maintain a high quality of life [3][4].

The Surveillance Routine

There is no “one-size-fits-all” schedule for MRIs, but your plan will be tailored based on your symptoms, your specific gene (such as CCM3, which may require closer watching), and your history of past bleeds [5][6].

  • Brain Imaging: Most patients undergo a brain MRI every 1 to 2 years using high-sensitivity SWI sequences [7][8]. These scans check for any “active” lesions or new micro-hemorrhages that haven’t caused symptoms yet [9].
  • The Importance of the Spine: In FCCM, cavernous malformations can also form in the spinal cord. Because spinal lesions can be more prone to causing symptoms if they bleed, doctors increasingly recommend a screening spine MRI, especially for children or those with a high brain lesion burden, even if no spinal symptoms are present [7][10].
  • Neuropsychological Health: Recent research highlights that “brain fog,” memory complaints, and cognitive fatigue are common in FCCM [11]. Your monitoring should include regular “check-ins” on your mental clarity and emotional well-being, not just your brain structure [11][12].

Daily Life, Pregnancy, and Activity

After a diagnosis, you may feel like you are walking on eggshells, wondering what is safe to do in your day-to-day life.

  • Physical Activity and Altitude: Moderate exercise is generally encouraged for overall health. The primary restriction is avoiding high-impact contact sports (like football or boxing) where traumatic head injury is likely [5]. Currently, there are no strict medical bans on flying or traveling to high altitudes, though extreme, prolonged high-altitude exposure (hypoxia) might theoretically be stressful to the vessels and should be discussed with your doctor [13].
  • Pregnancy and Hormones: For a long time, women were told that the hormones of pregnancy might increase the risk of a cavernoma bleeding. Recent, high-quality evidence suggests this is not the case—exposure to female hormones and the physiological stress of pregnancy do not significantly increase the risk of hemorrhage for most CCM patients [14][5]. You can absolutely have a family, but your care should be proactively coordinated between your neurosurgeon and a high-risk obstetrician.

Managing “Scanxiety”

It is very common to feel a spike in stress or anxiety in the weeks leading up to and following an MRI—a phenomenon often called scanxiety [15][16]. Knowing you have multiple lesions can make every headache or tingle feel like a potential emergency.

To manage this burden:

  • Education is Empowerment: Understanding that most lesions remain stable and that “watchful waiting” is a successful long-term strategy for the majority of patients can help lower distress [3].
  • Minimize the Wait: Ask your care team if results can be released through a patient portal within 24–48 hours to shorten the period of uncertainty [17].
  • Mindfulness and Support: Techniques like mindfulness, combined with support from genetic counselors or specialized therapists, can help you process the psychological weight of the diagnosis [17][18].

Life with FCCM: The Big Picture

While the diagnosis is permanent, your disability is not guaranteed. Research shows that patients with the familial form (FCCM) report a Health-Related Quality of Life (HRQoL) that is comparable to those with the sporadic form [4]. Many people with FCCM live full, active lives by focusing on what they can control: maintaining a healthy lifestyle, following their surveillance schedule, and working with a specialized team [4][19]. Your goal is not just to monitor a disease, but to protect your ability to live your life to the fullest.

Common questions in this guide

How often do I need an MRI if I have FCCM?
Most patients require a brain MRI every 1 to 2 years using high-sensitivity imaging to check for new or changing lesions. Your exact schedule will be tailored to your specific genetic mutation, symptoms, and medical history.
Do I need a spine MRI if I only have brain lesions?
Yes, doctors increasingly recommend a baseline screening spine MRI for FCCM patients, even without symptoms. Cavernous malformations can form in the spinal cord, and monitoring them early is important for proactive care.
Is it safe to get pregnant if I have FCCM?
Yes, recent evidence shows that pregnancy and female hormones do not significantly increase the risk of a cavernoma bleeding. You can safely have a family, but your care should be closely coordinated between your neurosurgeon and a high-risk obstetrician.
Can I exercise or play sports with FCCM?
Moderate exercise is highly encouraged for overall health. The main restriction is to avoid high-impact contact sports, such as football or boxing, where traumatic head injuries are likely to occur.
How can I manage the anxiety of waiting for my MRI results?
Managing 'scanxiety' is a normal part of living with FCCM. You can reduce stress by practicing mindfulness, working with a therapist, and asking your clinic if your MRI results can be released quickly to a patient portal.
Does FCCM cause memory issues or brain fog?
Yes, cognitive fatigue, brain fog, and memory complaints are commonly reported by patients with FCCM. It is important to discuss these symptoms with your care team so they can include cognitive health in your long-term monitoring plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific gene mutation and current lesion burden, what is the best MRI interval for me—annual, biennial, or longer?
  2. 2.Can we schedule a full spine MRI at my next check-up to ensure we have a complete 'neuroaxis' baseline?
  3. 3.Does this facility have a protocol for releasing MRI results quickly to help me manage my anxiety?
  4. 4.Are there neuropsychologists on staff who can evaluate any 'brain fog' or memory issues I may be experiencing?
  5. 5.If a new lesion or a small micro-hemorrhage is found but I have no symptoms, will my treatment plan change?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.

    Santos AN, Rauschenbach L, Saban D, et al.

    European journal of neurology 2022; (29(5)):1427-1434 doi:10.1111/ene.15253.

    PMID: 35060255
  2. 2

    Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations.

    Galvão GDF, Trefilio LM, Salvio AL, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024; (33(11)):107947 doi:10.1016/j.jstrokecerebrovasdis.2024.107947.

    PMID: 39181174
  3. 3

    Clinical course of patients with conservatively managed cerebral cavernous malformations.

    Sandmann ACA, Kempeneers MA, van den Berg R, et al.

    European stroke journal 2024; (9(3)):667-675 doi:10.1177/23969873241246868.

    PMID: 38624046
  4. 4

    Comparative Analysis of the Health-Related Quality of Life Between Patients with Familial and Sporadic Forms of Cerebral Cavernous Malformation.

    Cunha AM, da Fontoura Galvão G, Marcondes de Souza J

    World neurosurgery 2025; (198()):124023 doi:10.1016/j.wneu.2025.124023.

    PMID: 40306412
  5. 5

    Cerebral cavernous malformations - An overview on genetics, clinical aspects and therapeutic strategies.

    Dulamea AO, Lupescu IC

    Journal of the neurological sciences 2024; (461()):123044 doi:10.1016/j.jns.2024.123044.

    PMID: 38749279
  6. 6

    Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations.

    Fox CK, Nelson J, McCulloch CE, et al.

    Neurology 2021; (97(12)):e1210-e1216 doi:10.1212/WNL.0000000000012569.

    PMID: 34389651
  7. 7

    Spinal involvement in pediatric familial cavernous malformation syndrome.

    Geraldo AF, Luis A, Alves CAPF, et al.

    Neuroradiology 2022; (64(8)):1671-1679 doi:10.1007/s00234-022-02958-1.

    PMID: 35451625
  8. 8

    Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.

    Sparacia G, Speciale C, Banco A, et al.

    The neuroradiology journal 2016; (29(5)):326-35 doi:10.1177/1971400916665376.

    PMID: 27549150
  9. 9

    Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.

    Zeineddine HA, Girard R, Cao Y, et al.

    Journal of magnetic resonance imaging : JMRI 2018; (47(4)):1133-1138 doi:10.1002/jmri.25831.

    PMID: 28791783
  10. 10

    Natural course of untreated spinal cord cavernous malformations: a follow-up study within the initial 5 years after diagnosis.

    Santos AN, Rauschenbach L, Darkwah Oppong M, et al.

    Journal of neurosurgery. Spine 2022; (36(6)):1030-1034 doi:10.3171/2021.9.SPINE211052.

    PMID: 34920423
  11. 11

    Towards a neurocognitive profile in familial cerebral cavernous malformations.

    Silva C, Durães J, Lima M, et al.

    Acta neurologica Belgica 2024; (124(1)):49-54 doi:10.1007/s13760-023-02314-x.

    PMID: 37392320
  12. 12

    Association of Quality of Life Domains and Clinical Symptoms in Patients With Familial Cerebral Cavernous Malformation.

    Tsang C, Nelson J, Vassar R, et al.

    Journal of the American Heart Association 2025; (14(17)):e035926 doi:10.1161/JAHA.124.035926.

    PMID: 40879027
  13. 13

    Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling.

    Frias-Anaya E, Gallego-Gutierrez H, Gongol B, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2024; (44(6)):1246-1264 doi:10.1161/ATVBAHA.123.320367.

    PMID: 38660801
  14. 14

    Female hormone therapy and risk of intracranial hemorrhage and focal neurological deficits in patients with cavernous malformations of the central nervous system.

    Wildi S, Nager S, Staartjes V, et al.

    Frontiers in neurology 2025; (16()):1658980 doi:10.3389/fneur.2025.1658980.

    PMID: 41479609
  15. 15

    Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey.

    Bui KT, Kiely BE, Dhillon HM, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022; (30(1)):511-519 doi:10.1007/s00520-021-06454-9.

    PMID: 34333717
  16. 16

    Scanxiety: a scoping review about scan-associated anxiety.

    Bui KT, Liang R, Kiely BE, et al.

    BMJ open 2021; (11(5)):e043215 doi:10.1136/bmjopen-2020-043215.

    PMID: 34039571
  17. 17

    Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.

    Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.

    European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.

    PMID: 38311702
  18. 18

    A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the CCM1 Gene: A Case Report and Review of the Literature.

    Liu W, Liu M, Lu D, et al.

    Frontiers in neurology 2022; (13()):795514 doi:10.3389/fneur.2022.795514.

    PMID: 35444609
  19. 19

    Clinicoradiologic data of familial cerebral cavernous malformation with age-related disease burden.

    Kim S, Moon J, Jung KH, et al.

    Annals of clinical and translational neurology 2023; (10(3)):373-383 doi:10.1002/acn3.51728.

    PMID: 36629374

This page provides educational information on living with and monitoring Familial Cerebral Cavernous Malformation (FCCM). It is not a substitute for professional medical advice; always discuss your specific MRI schedule and lifestyle guidelines with your neurosurgeon.

Get notified when new evidence is published on Familial cerebral cavernous malformation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.